Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity

Evaluation of potential immunity against the novel severe acute respiratory syndrome (SARS) coronavirus that emerged in 2019 (SARS-CoV-2) is essential for health, as well as social and economic recovery. Generation of antibody response to SARS-CoV-2 (seroconversion) may inform on acquired immunity f...

Descripción completa

Detalles Bibliográficos
Autores principales: McAndrews, Kathleen M., Dowlatshahi, Dara P., Dai, Jianli, Becker, Lisa M., Hensel, Janine, Snowden, Laura M., Leveille, Jennifer M., Brunner, Michael R., Holden, Kylie W., Hopkins, Nikolas S., Harris, Alexandria M., Kumpati, Jerusha, Whitt, Michael A., Lee, J. Jack, Ostrosky-Zeichner, Luis L., Papanna, Ramesha, LeBleu, Valerie S., Allison, James P., Kalluri, Raghu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526535/
https://www.ncbi.nlm.nih.gov/pubmed/32796155
http://dx.doi.org/10.1172/jci.insight.142386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526535/
https://www.ncbi.nlm.nih.gov/pubmed/32796155
http://dx.doi.org/10.1172/jci.insight.142386

Ejemplares similares